A brief history of Aβ imaging

Area of Science:

• Neuroimaging
• Neuropathology
• Alzheimer's Disease Research

Background:

• Beta-amyloid (Aβ) pathology is a hallmark of Alzheimer's disease (AD).
• In vivo assessment of Aβ pathology has historically been challenging.
• Understanding the temporal dynamics of Aβ deposition is critical for AD.

Purpose of the Study:

• To highlight the revolutionary impact of Aβ imaging on AD assessment.
• To emphasize the diagnostic and therapeutic evaluation capabilities of Aβ imaging.
• To underscore the role of Aβ imaging in understanding disease progression.

Main Methods:

• Quantitative assessment of regional and global Aβ burden using in vivo imaging.
• Longitudinal studies correlating Aβ imaging with other biomarkers.
• Analysis of Aβ deposition in relation to clinical symptoms and disease staging.

Main Results:

• Aβ imaging provides accurate, reliable, and reproducible quantitative data on Aβ burden.
• Aβ deposition begins decades before symptom onset, as shown by longitudinal studies.
• Aβ imaging is essential for differential diagnosis, staging, and evaluating anti-Aβ therapies.

Conclusions:

• Aβ imaging has fundamentally changed the in vivo assessment of AD Aβ pathology.
• It offers crucial insights into the timeline and extent of Aβ deposition.
• Continued research refines our understanding of Aβ's role and its relationship with other biomarkers.